Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

JenaValve Technology GmbH

www.jenavalve.de

Latest From JenaValve Technology GmbH

FIRE1 Stokes Up €40m New Capital

FIRE1, an Irish start-up developing a digital remote monitoring technology for patients at risk of heart failure, has secured €40m in its biggest financing round to date. This series C brought in new European investors, including Gilde Healthcare, GIMV and Seventure.

Cardiology Financing

Market Intel: Relentless Rise Of Transcatheter Tech: Heart Valve Repair Turns Back On Open Surgery

The global market for products treating heart valve disease is expected to exceed $8bn by 2021, driven largely by the rising number of elderly patients with cardiovascular disease, obesity and growing prevalence of diabetes. This, in turn, is fueling significant innovation in minimally invasive techniques, particularly in the leading area of transcatheter aortic valve replacement (TAVR), but also in transcatheter mitral valve repair (TMVrep) systems, both of which offer patients quicker recovery times, less discomfort and greater safety compared to traditional surgical heart valve repair and replacement. This feature looks more closely at the competitive landscape and dynamics of these two fast-growing market segments, as well as gives insight into what the users – the physicians – think of these technologies.

Cardiovascular Surgical Procedures

People Briefs

Israeli firm Insightec appoints former Mako Surgical co-founder and chair as CEO, ACell taps new president and CEO, and more personnel updates from JenaValve Technology, Zeltiq and Reva Medical.

Medical Device Business Strategies

Execs On The Move, September 2015

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • JenaValve Technology GmbH
  • Senior Management
  • John T Kilcoyne, CEO
    Peter C Wulff, CFO
    Greg Mirigian, VP, R&D
    Vinny Podichetty, MD, VP, Clinical Affairs
    Jeff Thiel, VP, Operations
  • Contact Info
  • JenaValve Technology GmbH
    Phone: (49) 8955 279080
    Guerickestraße 25
    München, 80805
    Germany
UsernamePublicRestriction

Register